Life Science Nation Newsletter  |  January 21, 2016  |  Issue 146

  The LSN Story   |   Investor Platform   |   Company Platform   |   RESI Conference   |   Fundraising Accelerator
Life Science Investor Mandates (Jan. 7 - Jan. 20)
Seeks Pre-Revenue Medtech, Diagnostics & Healthcare IT
Seeks Medical Devices for China Market
Focuses On Novel Ophthamology Technologies
Focused On Clinical-Stage Biopharma Opportunities
In This Issue
LSN Videos
RESI Boston 2015 Investors Panel

Video Recap of [email protected] 2015

By Michael Quigley, VP of Market Research, LSN

On April 11th, Life Science Nation will be bringing together hundreds of senior level executives from investment firms, corporate strategics, and emerging biotech, medtech and digital health companies to the TMCx accelerator space at the Texas Medical Center in Houston. The recent RESI Conference in San Francisco had nearly 800 registrants and a full partnering floor.  The event drew so much interest that registration was shut down a week prior to the event - and we received many regretful notes from those who wished they'd signed up sooner!

In addition to the firepower that LSN brings to the table, TMCx will be showcasing their second class of digital health and medical device technologies which will be announced later this month, and JLABS will be bringing senior executives from Johnson & Johnson and a number of entrepreneurs from the JLABS incubators...

By Nono Hu, Director of Marketing, LSN

Last week, LSN's Redefining Early Stage Investments (RESI) Conference brought together approximately 350 early stage investors and 300 biotech, medtech and healthcare IT entrepreneurs, our largest crowd to date. The RESI Innovation Challenge received a record number of applicants last fall. The 30 most innovative applicants were hand selected by Life Science Nation's internal scientific review board and presented their technologies in an exhibition-style format throughout the full-day conference. Here are the top 3 winners!

First Prize Winner: ClearSight

George Ayd, Assistant Vice President, MedMarc, Shravanthi Reddy, COO, ClearSight

Second Prize Winner: Eve Medical

Michael Quigley, VP of Market Research, LSN, Jessica Ching, CEO, Eve Medical, Dennis Ford, CEO, LSN


Third Prize Winner: Briteseed

Michael Quigley, VP of Market Research, LSN, Mayank Vijay, Head of BD and Operations , Co-founder, Briteseed

By Lucy Parkinson, Director of Research, LSN

Congratulations to Clearsight, Eve Medical, and Briteseed for their success in the RESI Innovation Challenge last week; at LSN, we hope that the success of these companies in RESI's virtual fundraising challenge translates into real investor dollars!

If you're interested in seeing your company's name up there on the winner's list, you can now apply to the [email protected] Innovation Challenge for the conference on April 11, 2016. Successful applicants will be provided with a spot in the RESI Exhibitor Hall, and the challenge provides entrepreneurs with a way to engage with RESI's audience of active life science investors throughout the event. All RESI attendees are provided with "RESI Cash" tokens that they can allocate to the entrepreneurs whose technologies they expect will be most successful. At the end of the day, the capital invested will be tallied up and the top 3 participants will be announced...